LLY
Eli Lilly and Company
Stock
$1,184.78+1.32 (+0.11%)Close Sep 28, 2026
| Stock-based compensation (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $649M | +5.6% | 15.2% | 11.1% |
| Stock-based compensation (TTM) | $649M |
|---|---|
| YoY | +5.6% |
| 5-year CAGR | 15.2% |
| 10-year CAGR | 11.1% |
Stock-based compensation
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $626M | −3.1% |
| 2024 | $646M | +2.7% |
| 2023 | $629M | +69.5% |
| 2022 | $371M | +8.3% |
| 2021 | $343M | +11.3% |
| 2020 | $308M | −1.4% |
| 2019 | $312M | +11.8% |
| 2018 | $280M | −0.6% |
| 2017 | $281M | +10.2% |
| 2016 | $255M | +17.2% |
| 2015 | $218M | +39.6% |
| 2014 | $156M | +7.7% |
| 2013 | $145M | +2.4% |
| 2012 | $142M | −4.0% |
| 2011 | $147M | −36.2% |
| 2010 | $231M | −37.3% |
| 2009 | $369M | — |
| 2008 | −$255M | — |
| 2007 | −$282M | — |